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Ans H Tiessen1*, Andries J Smit2, Sebes Zevenhuizen3, Edwin M Spithoven2 and Klaas Van der Meer1Abstract
Background: Lower social economic status (SES) is related to an elevated cardiovascular (CV) risk. A pro-active
primary prevention CV screening approach in general practice (GP) might be effective in a region with a low mean
SES. This approach, supported by a regional GP laboratory, was investigated on feasibility, attendance rate and
proportion of persons identified with an elevated risk.
Methods: In a region with a low mean SES, men and women aged ≥50/55 years, respectively, were invited for
cardiovascular risk profiling, based on SCORE 10-year risk of fatal cardiovascular disease and additional risk factors
(family history, weight and end organ damage). Screening was performed by laboratory personnel, at the GP
practice. Treatment advice was based on Dutch GP guidelines for cardiovascular risk management. Response rates
were compared to those in five other practices, using the same screening method.
Results: 521 persons received invitations, 354 (68%) were interested, 33 did not attend and 43 were not further
analysed because of already known diabetes/cardiovascular disease. Eventually 278 risk profiles were analysed, of
which 60% had a low cardiovascular risk (SCORE-risk <5%). From the 40% participants with a SCORE-risk ≥5%, 60%
did not receive medication yet for hypertension/hypercholesterolemia. In the other five GPs response rates were
comparable to the currently described GP.
Conclusion: Screening in GP in a low SES area, performed by a laboratory service, was feasible, resulted in high
attendance, and identification and treatment advice of many new persons at risk for cardiovascular disease.
Keywords: General practice, Socio-economic status (SES), Cardiovascular risk management, ScreeningBackground
Management of cardiovascular risk factors in high-risk
persons in general practice is still poor, as shown by the
EUROASPIRE III 2006–2007 survey in 12 European
countries [1]. In the United Kingdom (UK) Joint British
Societies JBS 2 guidelines were proposed in 2005 for
prevention of cardiovascular disease (CVD) in the
asymptomatic population in clinical practice [2]. Record-
ing of CVD risk factors was also stimulated by the intro-
duction of the Quality and Outcomes Framework (QOF)
in 2004. The implementation of the National Health Ser-
vice Health Checks by the UK Department of Health has
been started in 2009, but has major implications for the
workload of general practices [3], especially due to vari-
able, but often incomplete baseline risk factor recording.* Correspondence: a.h.tiessen@umcg.nl
1University of Groningen, University Medical Center Groningen, Dept. General
Practice, Groningen, The Netherlands
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reproduction in any medium, provided the orIn several other countries initiatives have been taken
to assess the potential of general practice to improve
vascular disease prevention, such as the HIPS study in
Australia [4] and a CVD quality improvement prog-
ramme in Finland [5]. Population based screening for
cardiovascular disease has also been studied in the UK
using routinely available data from GP records (Epic-
Norfolk study) and was shown to perform reasonably
well [6]. Other approaches involve different health care
suppliers such as community pharmacies [7]. Still, the
large majority of primary prevention occurs in the pri-
mary care setting in general practices.
Up until recently, in Dutch general practice guidelines
a case finding approach was used for primary CVD pre-
vention. Recently however, a so-called ‘Prevention Visit’
approach for use in general practice has been introduced
and tested in the Netherlands [8,9]. 82% of the Dutch
population between 45–74 years prefers GP-based healthLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Visit, persons >45 years were invited to fill in a self-
report questionnaire to identify high risk individuals.
Response rates depended on the way persons were
approached, but were generally found to be poor to
moderate [9]. From the individuals invited by a personal
letter, followed by a reminder-letter, 33% filled in the
questionnaire and from the target population invited by
poster or leaflet in the GP waiting room, 1% filled in the
questionnaire. After this, medical consultation by gen-
eral practitioners was offered to the identified high risk
individuals. This consultation consisted of comprehen-
sive CVD risk factor assessment and treatment advice.
Acceptance by general practitioners of cardio metabolic
health checks is still slow, and may like the NHS Health
Checks suffer from the considerable time and work load
they impose.
Several studies, for example from Sweden, USA,
France and the UK, have investigated the relation be-
tween socio-economic status (SES) and cardiovascular
disease. Despite large regional differences between these
studies, with the SES based on educational level and/or
occupational group and CVD expressed as mortality,
morbidity and/or presence of risk factors, these studies
all found that higher SES is associated with lower CVD
risk [11-16]. Individuals with low SES more strongly pre-
fer CVD screening by their own GP (63% compared to
49% of the individuals with high SES, p<.001) [10]. Per-
haps, an active personal approach coming from their
own GP may be most successful for this target group.
In the present article, results are reported for CVD
risk factor detection and advice, antedating but partly
similar to the Dutch Prevention Visit described above.
Major differences with the Prevention Visit were that
possible participants were actively approached by invita-
tions on behalf of their GP (without prior selection
based on a questionnaire), and a regional GP laboratory
service and personnel performed the risk factor assess-
ment within the GP setting, to reduce workload for the
GP. A third difference is that for each participant, an in-
dividual GP guideline-based treatment and follow-up ad-
vice was given by the GP laboratory service, but its
execution was left to the discretion of the GP. This col-
laboration between laboratory services and GP practices
existed already in several Dutch regions for the treat-
ment of diabetes and showed improvements on control
frequency and glycaemic control with this intervention
compared to controls [17,18]. In this kind of collabor-
ation, GP laboratories usually offer a recall system for
regular patient check-ups, the results of which are
reported to the GP.
This study was performed in a general practice in a
municipality with a low SES status (1.6 standard devi-
ation below the Dutch average, based on income,employment and level of education of the postal code
region) [19] and markedly increased cardiovascular mor-
tality (the standardised mortality ratio is 124 (95% CI:
106–143), which means that CVD mortality standardised
for age is 24% higher than the Dutch average level) [20].
In the current report we addressed the following ques-
tions on the pro-active GP based approach, supported
by a GP laboratory, in a low SES-area: what are the re-
sponse rate and attendance rate at the screening of the
invitees and what are the reasons for non-attendance?
How many of those with risk profiles that were selected
for further analysis, appeared to be “new high risk
patients” i.e. high risk CVD patients without previously
receiving CVD-medication? Comparisons of response
and attendance rates are made with summary data for
the same approach in other municipalities. From these
other municipalities, one was located in a substantial
higher SES municipality. The yield of high risk patients
for the studied low mean SES municipality has been
compared to the yield in this higher SES municipality.
The comparison with this other practices was performed
to assess the external validity of the screening. Our hy-
pothesis is that with this approach the response rate and
attendance rate of the low SES municipality will equal
the other municipalities and we expect that the yield of
high risk patients will be higher in the low SES munici-
pality compared to a higher SES municipality.
Methods
Selection of participants
The screening was performed between April and
September 2008 in a general practice in Oude Pekela,
Eastern Groningen, with a population size of 2850
patients (the average GP practice number in the
Netherlands is 2350).
Male persons from 50 years on and females from
55 years on, without registered diabetes mellitus, were
preselected from this population using the computer
system for patient registration. Asylum seekers (80 per-
sons in this practice) were not approached because
follow-up often was not possible. The general practi-
tioner could furthermore exclude persons for whom
participation was considered inappropriate, for example
patients suffering severe dementia or persons with an
impaired life expectancy (estimated <2 years), together
13 persons in this practice, or incapacity to come to the
general practice due to a very old age or an enduring
bedridden condition, 24 persons. Current follow-up by
a cardiologist or internist (second line) was also an ex-
clusion criterion. Persons already receiving CV risk fac-
tor treatment (except diabetes) in a primary prevention
setting were included. Those with previous cardiovascu-
lar events, but not in second-line follow-up, were
invited for possible updating/ optimisation of secondary
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count in the further analysis below.
The selected persons received an information letter
and a response form on behalf of their general practi-
tioner. Respondents willing to participate all received an
invitation and a questionnaire (Additional file 1).
Each invitee received an appointment at the location
of the general practice, scheduled for half an hour.
The filled-in questionnaire was discussed with the rep-
resentative of the general practice service LabNoord
Groningen, usually a doctor’s assistant. This represen-
tative had previously received additional training for
taking the cardiovascular history and physical examin-
ation. Specific attention was given to performing blood
pressure measurements according to the guidelines.
The previously sent questionnaire consisted of the
following items: previous history and family history of
cardiovascular disease, hypertension, diabetes, lipid dis-
orders, medication use, smoking behaviour and phys-
ical exercise habits. The physical examination included
length, weight, BMI, and standardised blood pressure
measurement. Blood pressure was measured three
times on both arms; the mean of three measurements
on the arm with the highest blood pressure was used.
Additionally a 12-lead ECG, an albumin-creatinine ratio
in a morning urine sample, and non-fasting serum assays
of creatinine (with the estimated glomerular filtration
rate (eGFR)), glucose, potassium, total cholesterol, HDL-
cholesterol, LDL-cholesterol and triglycerides were
assessed. The ECG was examined by a cardiologist.
Using the collected data, for each attendant to the
screening, a report was composed for the general practi-
tioner by the GP laboratory service LabNoord. This
summarised the identified risk factors, the calculated
SCORE risk assessment (ten-year cardiovascular mortal-
ity risk) [21], and included advices for lifestyle and
pharmaceutical treatment, for possible second-line spe-
cialist referral advices, and for follow-up by the general
practitioner himself or LabNoord. The advices were
based on the SCORE assessment plus additional risk fac-
tors, in line with the Dutch GP guideline [22]. Add-
itional risk factors were: positive family history of first
degree relatives with cardiovascular disease <60 years,
overweight (BMI >27 kg/m2), symptoms of end organ
damage such as micro albuminuria (albumin/creatinine
ratio: ♀>3,5 /♂>2,5), eGFR <60 ml/min/1.73 m2, or left
ventricular hypertrophy on ECG. SES is not part of the
SCORE risk calculation. A vascular internist examined
the data and gave lifestyle pharmaceutical and follow-up
advices based on the Dutch cardiovascular risk manage-
ment GP guideline. The general practitioner received
this report approximately 2 weeks after the screening
visit, earlier in case of abnormal results requiring more
urgent action. Depending on the results and the advice,the screened person received a letter or call for a GP
visit to implement the lifestyle or pharmaceutical advices
and follow-up as chosen by the GP.
The screening performed by the general practitioner
in cooperation with the general practitioner’s labora-
tory was not registered at a medical ethics committee.
Comparable cooperative screening facilities between
general practitioners and the laboratory already existed
several years for diabetes mellitus and COPD. The par-
ticipating general practitioner in this study and the la-
boratory wanted to extend these screening facilities, in
the interest of the local patients. The region of the
general practice is known for its elevated cardiovas-
cular risk [20] and in general patients increasingly de-
mand medical screenings. With the current methods,
experiences from the diabetes screening could be used
to offer a screening programme embedded in a well-
organised setting with quality insurance including an
appropriate follow-up. Afterwards it was decided to
publish the findings of this - at least for the Netherlands
- novel initiative. All the procedures on the subjects as
described in our article were part of usual risk factor de-
tection, according to the Dutch cardiovascular risk man-
agement guidelines.
141 persons who did not respond or refused participa-
tion were asked half a year later by letter for the reasons
not to respond or participate.
As mentioned in the backgrounds, this study was per-
formed in a general practice in a municipality with a
SES status 1.6 standard deviation below the Dutch aver-
age, based on income, employment and level of educa-
tion of the postal code region [19]. We analysed whether
the postal code of the attendees was different from the
whole practice (excluding the asylum seekers), using
Fisher’s exact test 2-sided, to assess if these further ana-
lysed participants reflected the low SES population of
the practice.
After the first screening, the same approach was used
in five other general practices that were also already col-
laborating with LabNoord for the treatment of diabetes.
Four from these other practices were located at the town
of Stadskanaal, located in a municipality with a mean
SES of 1.4 standard deviation below the Dutch average
[19]. The fifth practice was located at Drachten, munici-
pality Smallingerland, with a mean SES of 0.6 standard
deviation below the Dutch average, which is substantially
higher than the other practices [19]. Summary response
rates of all five practices were compared to the described
practice, using Fisher’s exact test 2-sided. The yield in
identified persons with an elevated risk in the studied
practice has been compared to the general practice from
the higher SES municipality. For this municipality the
cardiovascular mortality is at a level comparable to
the average in the Netherlands (with a standardised
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substantially higher than the studied practice [23].
Results
As shown in Figure 1, 591 individuals were preselected
from the patient database. These were individuals in the
requested age category, being no asylum seeker and
without registered diabetes or conditions considered in-
appropriate for participation. In the next step 69 indivi-
duals being under second line follow up and 1 person
that had deceased were excluded.
521 persons were sent a letter inviting them for par-
ticipation. 18% did not respond, 14% were not inter-
ested in participation and 68% responded positively
and were invited for a screening visit. 91% of these
invitees (which is 62% of all persons that were sent an
invitation letter) attended the screening. 11 persons









354 invited for practicevisit (68%)
33 no attendance:
12 cancelled, 21 no turn up
321 attended screening (91%)
11 diabetes
32 history of cardiovascular disease




Figure 1 Flow of patients.had an increased glucose level but had not been noted
in the practice registry as having diabetes. 32 persons
had suffered previous cardiovascular events. The risk
profiles of these latter two groups were assessed but
not used in the further analysis below. The remaining
278 risk profiles were analysed further.
From these 278 analysed risk profiles, 59.7% (95% CI:
53.7 – 65.5, n=166) had a low cardiovascular risk, being
in the category <5% ten-year cardiovascular mortality
risk. 30.1% (95% CI: 23.3 – 37.7, n=50) of this low risk
group used pharmaceutical treatment for hypertension
and/or hypercholesterolemia, and were known using
this treatment in the general practice. Below the age
of 65 years, 78.1% (143/183; 95% CI: 71.4 – 83.9) had
a low risk (<5%), between 50 and 55 years (only men)
this was 91.7% (33/36; 95% CI: 77.5 – 98.2) (Figure 2).
14.0% (95% CI: 10.2 – 18.7, n=39) of the 278 analysed
participants had an intermediate cardiovascular risk167 no response/no interestin CVR
analysis
141 questionnaires on non-
participation
26 could not be reached
61 no response to questionnaire on
non-participation





Figure 2 Distribution of SCORE risk categories for different age groups in the studied general practice.
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(95% CI: 21.2 – 31.8, n= 73) had an increased risk
(5-10% with additional risk factors or ≥10%). Of the
complete group with a risk ≥5%, 40.2% (45/112; 95%
CI: 31.0 – 49.9) was already being treated for hyper-
tension or hypercholesterolemia, but was nevertheless
in the intermediate or high risk group. 24.1% (95% CI:
19.2 – 29.6, n = 67) of all 278 analysed participants
were individuals with a (moderately) increased risk
(≥5%), without previously receiving pharmaceutical
treatment for hypertension or hypercholesterolemia.
95% of all analysed risk profiles and 93% of the whole
general practice population (p=.22) lived in the postal
code region with the SES status −1.6 SD below the mean
of the Netherlands [19].
80 of 141 questionnaires on non-participation
were returned, see Figure 1. Given reasons for non-
participation were combinations of not being convincedTable 1 Proportions of non-responders, individuals who were




Similar screening in 5
N (%)
No response 95 (18.2) 358 (19.1)
No interest 72 (13.8) 353 (18.8)
Invitation 354 (67.9) 1163 (62.1)
Attendance at screening
(% of invitees)
321 (90.7) 1090 (93.7)of usefulness, the wish not to know the CV risk, being
afraid of unwanted results (24), lack of time (16), and fi-
nancial costs (13). The remaining category (27) men-
tioned reasons including: age, other health problems,
missed call or combinations of these.
Response rates and yield for use of the current model
in five other general practices in other cities and regions
in the northern part of the Netherlands, also in a higher
SES class region are shown in Table 1 (Ref: unpublished
data from the CV screening at Drachten and Stadskanaal,
LabNoord Groningen; 2009). Compared with the 1874
initially addressed persons in these other practices, the
proportion of person who were not interested was slight-
ly lower (13.8% vs. 18.8%) and related to this, the pro-
portion invitees was slightly higher (67.9% vs. 62.1%) in
the studied practice, with the proportions being in the
range that was also found for the other practices. The yield
in identified persons with an elevated risk has beennot interested, invitees and attenders at the screening
er GPs
other GPs (total 1874 information letters) Difference between
Oude Pekela and
5 other GPs P-value
Highest-Lowest GP
10% – 32% .70
13% – 27% .01
51 – 72% .01
88% – 100% .06
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city with a cardiovascular mortality at a level comparable
to the average in the Netherlands [23], which is consider-
ably lower than in the currently reported low SES mu-
nicipality. In this practice in the area with a lower
cardiovascular risk, 29.6% (95% CI: 23.4 – 36.5) was
found to have a SCORE risk assessment ≥5% compared to
40.3% (95% CI: 34.5 – 46.3) in the current study
group; with the difference between both proportions
being 10.6% (95% CI: 2.06 – 19.20).
Discussion
This primary prevention CV risk screening, performed
within the general practice with logistical support of the
regional general practice laboratory and service, could
be well managed within the GP setting, and resulted in a
limited additional workload for the GP and his assistant.
The GP was only involved in the selection of the
patients and provided the location within his practice.
The response rate and attendance of the invitees was
high, when compared to the Dutch Prevention Visit for
example. The yield in newly identified persons (i.e. not
currently treated already for hypertension or hyperchol-
esterolemia) with increased risk was considerable (24%
of the analysed participants). Compared to a practice
from an area with a lower cardiovascular mortality, the
yield in identified high risk patient was higher in the
studied practice, as expected. Compared to the five prac-
tices with similar screenings, the proportion of indivi-
duals that was interested after written invitation and
could be invited for the risk assessment, was even
slightly higher in the studied practice.
The percentage of individuals that had received an in-
vitation letter and was eventually invited for the screen-
ing (68%) is comparable with the results of the Dutch
ResCon research agency, which assessed by question-
naires in 45–74 year old persons their willingness to par-
ticipate in a health check for early detection of cardio
metabolic risk: 66% reported to probably or surely be
willing to undergo a health check [10]. Likely reasons for
the good attendance are the invitation by their own gen-
eral practitioner, the screening location within the gen-
eral practice and the reimbursement by the health
insurance provider (depending on the remaining own
risk) [10]. The response rate was considerably higher
than during the pilot of the Dutch national Prevention
Visit. The admission age was higher in the present study,
which is related to a higher response [24-26]. For ex-
ample, Van de Kerkhof et al. found that respondents at a
cardiovascular risk factor screening were significantly
older than non-responders (52.7 vs. 49.5 years, p<.001)
[24]. Besides, a considerable number of the analysed par-
ticipants already used medication and thus was already a
regular visitor of the practice. These people probablyexperience fewer barriers to participate in a medical
programme.
Both in the pilot study of the Prevention Visit as well
as in the study by Van de Kerkhof et al. a questionnaire
was used as first selection step [9,24]. The dependence
on a questionnaire to be filled in by possible candidates
as a first filter for a cardio metabolic screening seems to
be less efficient in identifying high risk people than in-
creasing the admission age from 40 to 50 years [27]. In
the present study even in the 50–55 years range, the
large majority (92%) of men was in the low risk range.
Active invitation is needed to additionally obtain infor-
mation on missing or incompletely available risk factors
for an adequate assessment and identification of high
CVD risk patients, as is shown in our and the Preven-
tion Visit pilot studies [9], but also in the UK primary
care setting [28].
In the present municipality with a low average SES
and increased mortality for cardiovascular disease, the
target group had a high response rate with the current
approach. Thus, an active screening as performed in the
current study seems to be an answer to the demand
for a reliable risk assessment in such a low SES group.
The expectation that many undertreated persons with
increased risk would be identified using the approach via
their general practice was confirmed.
A limitation of the currently reported data of only one
specific general practice situation may be that the exter-
nal validity is limited. However, use of the currently
described model of CV risk screening within a general
practice, in several other general practices in other cities
and regions in the northern part of the Netherlands, also
in a higher SES class region, revealed no major differ-
ences in response rates and yield.
The participating general practitioners, both from the
studied practice and from the other municipalities, may
be more motivated for improving cardiovascular screen-
ing and adjusting practice organisation than average
practices, as this was a novel initiative. This may over-
estimate the effect.
Within the 40% of the further analysed participants
with a SCORE risk assessment ≥5% already using
pharmaceutical treatment for the risk factors, many were
not on the target levels as advised in Dutch and other
national CV guidelines. Similar observations have often
been made in primary as well as in secondary care
[1,29]. This group received additional advice as sug-
gested in the guidelines. It illustrates that extension of
the current health check model to those in a general
practice already receiving pharmaceutical treatment for
cardiovascular risk factors may still have added value.
In the described current CV screening model, males
were invited >50 years and females >55 years, because
SCORE risk assessments are to a large extent
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for lifestyle or even pharmaceutical treatment above
these age levels [21]. In other health check risk screening
programs, such as the NHS Health Checks programme,
but also in the Dutch Prevention Consultation, younger
age limits such as 40 or 45 years are used [3,9]. Current
JBS charts allow assessments for three age ranges: <50,
50–59 and ≥60 years. We are aware that use of the lower
age limit better takes into account that younger patients
have greater lifetime risk. One may also argue that low-
ering the admission age has the second advantage of
offering a time window for benefits from lifestyle modifi-
cation with an otherwise still expectant policy. However,
we weighed this against a broader acceptance (at least in
the Netherlands) of the SCORE risk categories as quali-
fiers for treatment. Using the currently used age limits,
only 8% of the males between 50–55 years did have a
SCORE risk assessment ≥5%.
In the current model the logistics and execution of the
screening programme and health checks were performed
by a regional general practice laboratory and service.
Advantages are that the health checks may be performed
in or in the neighbourhood of the general practices, and
invitees are examined by trained personnel but still
under supervision of the general practitioner. Dalton
et al. [3] have already discussed the impact of the sub-
stantial extra workload of NHS Health Checks and simi-
lar screening programmes for the GPs. Involvement of
GP laboratory personnel that organises and performs the
screening program within the GP practice may alleviate
such extra workload. In 2008 a Dutch NIVEL question-
naire addressed to 330 general practitioners revealed
that 94% consider the general practice as the preferred
place for detecting high cardiovascular risk patients
[30,31]. A general practice laboratory was considered the
preferred institution for delegation of GP tasks (33.7%
agreed/agreed very much, this was the highest percent-
age of all given options, which were, amongst others:
hospital, pharmacy, municipal public health service)
[31]. Although the general practice is well-equipped to
perform follow-up for pharmaceutical treatment in the
detected persons with increased CV risk, a first or paral-
lel step of lifestyle advices may require further involve-
ment and cooperation with dieticians or physical
therapists. Practice nurses within the general practice al-
ternatively may offer integrated advice on lifestyle and
pharmaceutical treatment. For long-term follow-up of
treatment results health checks after follow-up periods
ranging between one and five years may be repeated
using the current model.
Conclusions
Pro-active GP based cardiovascular screening, supported
by a GP laboratory, in a low SES-area could be wellimplemented and resulted in a high response rate of
invited persons, and a high yield of newly detected
persons with increased risk. Apparently, in the studied
practice, it is possible with the current approach to ef-
fectively detect those with increased cardiovascular risk
within the target group of persons with low mean so-
cial economic status. Further research questions that
have to be answered before this approach should be
broadly implemented are: whether this approach is ef-
fective in other GPs in low SES-areas, whether the ap-
proach is cost-effective and which positive effects on
(long term) cardiovascular risk can be achieved in the
individuals found to have an elevated cardiovascular
risk.
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